LGALS9 and neoplasm: Loss of gal9 in DCs delayed antitumor responses as tumor burden in cd11ccrelgals9fl/fl mice was larger as compared to WT and gal9−/− mice after day 14 and until day 25 post tumor inoculation (Fig. 6 A and B).